Ence Chuck

Track

Insider profile

Performance

Overall performance
3.4
Performance over holding periods
3.4
30 days 90 days 120 days
Average return 61% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
4 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Ence Chuck's trades of Relmada Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
478.44
Quantity 70,299 -1.0%
Value US$2,119,146
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-06 2025-11-05
B Purchase
70,299 -1.0%
478.44
US$2,119,146 		70,299 -1.0% 478.44 US$2,119,146
2025-05-20 2025-05-16
B Purchase
39,505 +28.4%
148.27
US$2,645,762 		39,505 +28.4% 148.27 US$2,645,762
2024-01-31 2024-01-31
B Purchase
33,425 -47.0%
435.33
US$4,866,469 		33,425 -47.0% 435.33 US$4,866,469
2024-01-31 2024-01-30
B Purchase
14,500 +134.3%
3.87
US$56,053 		14,500 +134.3% 3.87 US$56,053
2024-01-31 2024-01-29
B Purchase
10,800 +inf%
3.65
US$39,438 		10,800 +inf% 3.65 US$39,438